4519:TSEChugai Pharmaceutical Co., Ltd. Analysis

At ¥6,847.00, Chugai Pharmaceutical Co., Ltd. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 10.4%. RSI sits at 42.1, which reads as neutral, and MACD momentum is bullish. The recent range runs from support at ¥6,575.00 up to resistance at ¥7,509.00.
The shares look undervalued, trading on 23.9 times earnings below a sector average of 30.2. Consensus targets land 36.6% above where the shares trade now. Revenue is growing at 17.8% on a 35.1% profit margin. The 1.92% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 36.3%, a beta of 0.18 and a maximum drawdown of 36.1%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.